Art. No.: RBRP89 / RBRP89B
Multi-mycotoxin immunoaffinity columns for simultaneous detection of aflatoxins B1, B2, G1, G2 and ochratoxin A in a wide range of commodities in conjunction with HPLC or LC-MS/MS.
The procedure is based on monoclonal antibody technology, which makes the test highly specific, sensitive, rapid and simple to perform. Improved clean-up and concentration of toxins from complex food matrices results in reduced chromatography interference and lower detection limits. The columns contain a gel suspension of monoclonal antibodies specific to the toxins of interest. Following extraction of the toxins the sample extract is filtered, diluted and passed slowly through the immunoaffinity column. Any toxins which are present in the sample are retained by the antibody within the gel suspension. The column is washed to remove unbound material and the toxins are then released from the column following elution with solvent. The eluate is collected and injected prior to analysis by HPLC or LC-MS/MS. Aflatoxins are required to be derivatised when analysed by HPLC.
- The columns have been validated and approved by Nestlé.
- One sample preparation and extraction for the analysis of aflatoxins and ochratoxin, saving time.
- Simultaneous detection of aflatoxins and ochratoxin in a single HPLC run. Alternatively, analysis can be performed in a single LC-MS/MS run.
we now provide the documents for our products in an electronic format which include the Instructions for Use (IFU), Safety Data Sheets (SDS), Application notes and the Certificate of Analysis (CoA). For batches placed on the market after 1st June 2023, you can find our documents on the eIFU portal eifu.r-biopharm.com.
|Art. No||RBRP89 / RBRP89B|
|Test format||RBRP89: 10 immunoaffinity columns|
(1 ml format),
RBRP89B: 50 immunoaffinity columns
(1 ml format)
|Sample preparation||A representative sample should be obtained by following an officially recognised sampling procedure. Sample is extracted using solvent (Extraction solvent can vary depending on commodity analysed), filtered and diluted ready for applying to the immunoaffinity column.|
|LOD (Detection Limit)||Information provided is typical LOD obtained by R-Biopharm. Please note that this is dependant on method, LC conditions and equipment used. |
B1 0.0079 ng/ml, B2 0.0079 ng/ml, G1 0.0157 ng/ml, G2 0.0079 ng/ml, OTA 0.0125 ng/ml.
B1 0.007 ng/ml, B2 0.007 ng/ml, G1 0.004 ng/ml, G2 0.015 ng/ml, OTA 0.050 ng/ml
Aflatoxin B1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2 and Ochratoxin A and Ochratoxin B. May also cross react with other metabolites.
|Available application notes|
Methods are available for all matrices covered by legislation as well as additional commodities. Please contact your local R-Biopharm distributor for further information.
|Evaluation||HPLC or LC-MS/MS.|
|Approvals||The product meets all Official Method recovery and capacity specifications.|